Ledger.Open graph →
SEC Form D · filed September 7, 2021

Nutcracker Therapeutics, Inc

Offering
$200.0M
Sold
$144.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
EMERYVILLE, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Madhavan Balachandran · Emeryville, CAExecIgor Khandros · Emeryville, CAExec · DirectorRobert Nelsen · Seattle, WADirectorBenjamin Eldridge · Emeryville, CAExecJames Zhu · Sunnyvale, CAExecSamuel Deutsch · Emeryville, CAExecRobert Nelsen · Hampton, NJDirectorBenjamin Eldridge · Emeryville, CAExecMadhavan Balachandran · Emeryville, CAExecJames Zhu · New Haven, CTExecIgor Khandros · Emeryville, CAExec · DirectorSamuel Deutsch · Emeryville, CAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗